Dr Louis A Reines, MD,MBA | |
46 Obery St, Plymouth, MA 02360 | |
(508) 746-6385 | |
Not Available |
Full Name | Dr Louis A Reines |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 19 Years |
Location | 46 Obery St, Plymouth, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225236151 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 247099 (Massachusetts) | Secondary |
208C00000X | Colon & Rectal Surgery | 247099 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Claxton-hepburn Medical Center | Ogdensburg, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Claxton Medical Pc | 0244389153 | 28 |
Claxton-hepburn Medical Center | 8426966508 | 65 |
News Archive
At the 2021 EULAR congress, Brkic and colleagues presented data from people with rheumatoid arthritis (RA)treated at Norwegian rheumatology outpatient clinics between 2010 and 2019.
Scientists at Jefferson Medical College have received a four-year, $3 million National Institutes of Health grant funded by the National Heart, Lung and Blood Institute to study variations of platelet function, specifically, the genetics of platelet gene expression. The study aims to find data that can be translated into novel therapeutic strategies and develop better predictors of cardiovascular disease.
Advantech, a leading provider of industrial computing platform solutions, is pleased to announce its real-time location system (RTLS) solution-ready package (SRP) designed for real-time locating and monitoring of medical equipment, staff, and patients.
The clot-inhibiting drug apixaban was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint.
› Verified 2 days ago
Entity Name | Claxton-hepburn Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891753034 PECOS PAC ID: 8426966508 Enrollment ID: O20031110000552 |
News Archive
At the 2021 EULAR congress, Brkic and colleagues presented data from people with rheumatoid arthritis (RA)treated at Norwegian rheumatology outpatient clinics between 2010 and 2019.
Scientists at Jefferson Medical College have received a four-year, $3 million National Institutes of Health grant funded by the National Heart, Lung and Blood Institute to study variations of platelet function, specifically, the genetics of platelet gene expression. The study aims to find data that can be translated into novel therapeutic strategies and develop better predictors of cardiovascular disease.
Advantech, a leading provider of industrial computing platform solutions, is pleased to announce its real-time location system (RTLS) solution-ready package (SRP) designed for real-time locating and monitoring of medical equipment, staff, and patients.
The clot-inhibiting drug apixaban was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint.
› Verified 2 days ago
Entity Name | Carthage Area Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053497388 PECOS PAC ID: 9931010485 Enrollment ID: O20040209000856 |
News Archive
At the 2021 EULAR congress, Brkic and colleagues presented data from people with rheumatoid arthritis (RA)treated at Norwegian rheumatology outpatient clinics between 2010 and 2019.
Scientists at Jefferson Medical College have received a four-year, $3 million National Institutes of Health grant funded by the National Heart, Lung and Blood Institute to study variations of platelet function, specifically, the genetics of platelet gene expression. The study aims to find data that can be translated into novel therapeutic strategies and develop better predictors of cardiovascular disease.
Advantech, a leading provider of industrial computing platform solutions, is pleased to announce its real-time location system (RTLS) solution-ready package (SRP) designed for real-time locating and monitoring of medical equipment, staff, and patients.
The clot-inhibiting drug apixaban was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint.
› Verified 2 days ago
Entity Name | Claxton Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114164944 PECOS PAC ID: 0244389153 Enrollment ID: O20090526000410 |
News Archive
At the 2021 EULAR congress, Brkic and colleagues presented data from people with rheumatoid arthritis (RA)treated at Norwegian rheumatology outpatient clinics between 2010 and 2019.
Scientists at Jefferson Medical College have received a four-year, $3 million National Institutes of Health grant funded by the National Heart, Lung and Blood Institute to study variations of platelet function, specifically, the genetics of platelet gene expression. The study aims to find data that can be translated into novel therapeutic strategies and develop better predictors of cardiovascular disease.
Advantech, a leading provider of industrial computing platform solutions, is pleased to announce its real-time location system (RTLS) solution-ready package (SRP) designed for real-time locating and monitoring of medical equipment, staff, and patients.
The clot-inhibiting drug apixaban was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Louis A Reines, MD,MBA 375 Longwood Ave Ste 3, Boston, MA 02215-5395 Ph: (617) 632-7441 | Dr Louis A Reines, MD,MBA 46 Obery St, Plymouth, MA 02360 Ph: (508) 746-6385 |
News Archive
At the 2021 EULAR congress, Brkic and colleagues presented data from people with rheumatoid arthritis (RA)treated at Norwegian rheumatology outpatient clinics between 2010 and 2019.
Scientists at Jefferson Medical College have received a four-year, $3 million National Institutes of Health grant funded by the National Heart, Lung and Blood Institute to study variations of platelet function, specifically, the genetics of platelet gene expression. The study aims to find data that can be translated into novel therapeutic strategies and develop better predictors of cardiovascular disease.
Advantech, a leading provider of industrial computing platform solutions, is pleased to announce its real-time location system (RTLS) solution-ready package (SRP) designed for real-time locating and monitoring of medical equipment, staff, and patients.
The clot-inhibiting drug apixaban was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint.
› Verified 2 days ago